Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,814 | -11,643 | -8,373 | -5,733 | -3,292 |
| Depreciation Amortization | 16 | 84 | 66 | 46 | 23 |
| Accounts payable and accrued liabilities | -227 | 589 | 10 | N/A | 441 |
| Other Working Capital | 490 | 544 | 395 | -47 | 584 |
| Other Operating Activity | 2,481 | 203 | 518 | 441 | -409 |
| Operating Cash Flow | $-4,054 | $-10,223 | $-7,384 | $-5,293 | $-2,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -13 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -2,985 | N/A |
| Sale Of Investment | N/A | -798 | -2,994 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 40 | 19 | 8 |
| Investing Cash Flow | $-24 | $-811 | $-2,954 | $-2,966 | $8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,860 | 14,025 | 10,203 | 8,204 | 3,676 |
| Other Financing Activity | -5 | -307 | 0 | 0 | 0 |
| Financing Cash Flow | $8,855 | $13,718 | $10,203 | $8,204 | $3,676 |
| Exchange Rate Effect | N/A | 7 | 98 | 50 | 21 |
| Beginning Cash Position | 10,631 | 7,940 | 7,940 | 7,940 | 7,940 |
| End Cash Position | 15,408 | 10,631 | 7,903 | 7,935 | 8,992 |
| Net Cash Flow | $4,777 | $2,691 | $-37 | $-5 | $1,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,054 | -10,223 | -7,384 | -5,293 | -2,653 |
| Capital Expenditure | -24 | -13 | N/A | N/A | N/A |
| Free Cash Flow | -4,078 | -10,236 | -7,384 | -5,293 | -2,653 |